Association between cadmium and breast cancer risk according to estrogen receptor and human epidermal growth factor receptor 2: Epidemiological evidence

Breast Cancer Research and Treatment

Volumn 145, Issue 1, 2014, Pages 225-232

  Strumylaite, Loreta ^a   Kregzdyte, Rima ^a   Bogusevicius, Algirdas ^a   Poskiene, Lina ^a   Baranauskiene, Dale ^a   Pranys, Darius ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Breast cancer; Cadmium; Case control study; Estrogen receptors; Human epidermal growth factor receptor 2; Urine

Indexed keywords

ALCOHOL; CADMIUM; CREATININE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ERBB2 PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; BIRTH RATE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HORMONAL THERAPY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; TISSUE DISTRIBUTION; AGED; ATOMIC ABSORPTION SPECTROMETRY; BREAST NEOPLASMS; CASE CONTROL STUDY; GENETICS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; QUESTIONNAIRE; URINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CADMIUM; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; QUESTIONNAIRES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; SPECTROPHOTOMETRY, ATOMIC;

EID: 84900491063     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2918-6     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. Cancer J Clin 61:69-90. doi: 10.3322/caac.20107
2. Coyle YM (2004) The effect of environment on breast cancer risk. Breast Cancer Res Treat 84:273-288. doi: 10.1023/B:BREA.0000019964.33963.09
3. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Kosenvuo M, Pukkula E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer. N Eng J Med 343:78-85
4. IARC (1993) Monographs on the evaluation of carcinogenic risks to humans. IARC, Lyon, pp 119-237
5. McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, Newcomb PA (2006) Cadmium exposure and breast cancer risk. J Natl Cancer Inst 98:869-872. doi: 10.1093/jnci/djj233
6. Gallagher CM, Chen JJ, Kovach JS (2010) Environmental cadmium and breast cancer risk. Aging 2:804-814. doi: 10.1016/j.envres.2011.03.007
7. Nagata C, Nagao Y, Nakamura K, Wada K, Tamai Y, Tsuji M, Yamamoto S, Kashiki Y (2013) Cadmium exposure and the risk of breast cancer in Japanese women. Breast Cancer Res Treat 138:235-239. doi: 10.1007/s10549-013-2414-4
8. Antila E, Mussalo-Rauhamaa H, Kantola M, Atroshi F, Westermarck T (1996) Association of cadmium with human breast cancer. Sci Total Environ 186:251-256. doi: 10.1016/0048-9697(96)05119-4
9. Ionescu JG, Novotny J, Stejskal V, Latsch A, Blaurock-Busch E, Eisenmann-Klein M (2006) Increased levels of transition metals in breast cancer tissue. Neuroendocrinol Lett 27(suppl. 1):36-39
10. Strumylaite L, Bogusevicius A, Ryselis S, Pranys D, Poskiene L, Kregzdyte R, Abdrachmanovas O, Asadauskaite R (2008) Association between cadmium and breast cancer. Medicina (Kaunas) 44:415-420
11. Strumylaite L, Bogusevicius A, Abdrachmanovas O, Baranauskiene D, Kregzdyte R, Pranys D, Poskiene L (2011) Cadmium concentration in biological media of breast cancer patients. Breast Cancer Res Treat 125:511-517. doi: 10.1007/s10549-010-1007-8
12. Garcia-Morales P, Saceda M, Kenney N, Kim N, Salomon DS, Gottardis MM, Solomon HB, Sholler PF, Jordan VC, Martin MB (1994) Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem 269:16896-16901
13. Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, Clarke R, Sholler PF, Lirio AA, Foss C, Reiter R, Trock B, Paik S, Martin MB (2003) Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 9:1081-1084. doi: 10.1038/nm902
14. Benbrahim-Tallaa L, Tokar EJ, Diwan BA, Dill AL, Coppin JF, Waalkes MP (2009) Cadmium malignantly transforms normal human breast epithelial cells into a basal-like phenotype. Environ Health Perspect 117:1847-1852. doi: 10.1289/ehp.0900999
15. Huang D, Zhang Y, Qi Y, Chen C, Ji W (2008) Global DNA hypomethylation, rather than reactive oxygen species (ROS), a potential facilitator of cadmium-stimulated K562 cell proliferation. Toxicol Lett 179:43-47. doi: 10.1016/j.toxlet.2008.03.018
16. Stoica A, Katzenellenbogen BS, Martin MB (2000) Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol 14:545-553. doi: 10.1016/j.taap.2006.04.002
17. Siewit LC, Gengler B, Vegas E, Puckett R, Louie MC (2010) Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ER alpha and c-Jun. Mol Endocrinol 24:981-992. doi: 10.1210/me.2009-0410
18. Le Guével R, Petit FG, Goff PL, Métivier R, Valotaire Y, Pakdel F (2000) Inhibition of rainbow trout (Oncorhynchus mykiss) estrogen receptor activity by cadmium. Biol Reprod 63:259-266. doi: 10.1095/biolreprod63. 1.259
19. Silva E, Lopez-Espinosa MJ, Molina-Molina J-M, Fernández M, Olea N, Kortenkamp A (2006) Lack of activity of cadmium in in vitro estrogenicity assays. Toxicol Appl Pharmacol 216:20-28
20. Aquino NB, Sevigny MB, Sabangan J, Louie MC (2012) The role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not? J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 30:189-224. doi: 10.1080/10590501.2012.705159
21. Nordberg GF, Nogawa K, Nordberg M, Friedmann JM (2007) Cadmium. In: Nordberg GF, Fowler BA, Nordberg M, Friberg L (eds) Handbook on the Toxicology of Metals. Elsevier, Amsterdam, pp 445-486
22. Strumylaite L, Kregzdyte R, Rugyte DC, Bogusevicius A, Mechonosina K (2013) Assessment of a questionnaire for breast cancer case-control studies. Asian Pac J Cancer Prev 14:2777-2782. doi: 10.7314/APJCP.2013.14.5.2777
23. Schlemmer G (1989) Analysis of biological chemical materials by graphite furnace-AAS. Instrumentalized analytical chemistry and computer technology. GIT, Asfeld, pp 561-568
24. DAKO (1996) Reference in immunohistochemistry. In: Breast cancer diagnosis, therapy and prognosis, 3rd edn. DAKo A/S, Glostrup, pp 1-9
25. Elinder CG (1985) Normal values for cadmium in human tissues, blood, and urine in different countries. In: Friberg L, Elinder CG, Kjellstrom T, Nordberg GF (eds) Cadmium and health: a toxicological and epidemiological appraisal. Exposure, dose, and metabolism. CRC Press, Boca Raton, pp 81-102
26. Cypress Diagnostics (2005) Creatinine. Kinetic test. Jaffe. Without deproteinization. Code HB008. Cypress Diagnostics, Belgium
27. Hammond MEH, Hayes DF, Wolff AC, Mangu PB, Temin S (2010) American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract 6:195-197. doi: 10.1200/JOP.777003
28. Wolff AC, Hammond MEH, Schwartz JN et al (2007) American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131:18-43. doi: 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2
29. Nordberg G (1993) Cadmium. In: Beije B, Lundberg P (eds) Criteria documents from the Nordic expert group 1992. National Institute of Occupational Health, Solna, pp 85-124
30. Järup L, Åkesson A (2009) Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 238:201-208. doi: 10.1016/j.taap.2009.04.020
31. Kippler M, Ekström EC, Lönnerdal B, Goessler W, Akesson A, Arifeen SE, Persson LA, Vahter M (2007) Influence of iron and zinc status on cadmium accumulation in Bangladeshi women. Toxicol Appl Pharmacol 222:221-226. doi: 10.1016/j.taap.2007.04.009
32. Joseph P (2009) Mechanisms of cadmium carcinogenesis. Toxicol Appl Pharmacol 238:272-279. doi: 10.1016/j.taap.2009.01.011